Luteolin is effective in the non‐small cell lung cancer model with<scp>L</scp>858<scp>R</scp>/<scp>T</scp>790<scp>M EGF</scp>receptor mutation and erlotinib resistanceZhuan Hong, Lan Luo, Na Li et al.|British Journal of Pharmacology|2014Cited by 69